GREEN BIO · PRECISION SMART FARM

Engineered by Data,Grown by Design.

We develop and produce plant green bio materials standardized to API grade on a precision-control smart farm.

MAT regulates plant metabolic pathways to reproduce the same quality every batch, regardless of season or climate.

Discuss a Partnership Explore the Technology

BATCH · WSB-2026-001

Woori Smart Bio

YEONCHEON · KR

SAPONIN · +8×

pH 5.8 · EC 1.4

μmol UV-B · 285nm

BATCH · WSB-2026-001

OBSERVED · CONTROLLED PLANT

OBSERVEDBATCH · WSB-2026-001

SAPONIN · +8×

pH 5.8 · EC 1.4

μmol UV-B · 285nm

ESTABLISHED
PATENTS: Green Bio
CERTIFICATION: Venture
STATUS: Yeoncheon
FACILITY
CAPA

01BUSINESS

Material buyers & brands

Standardized functional botanical materials and ODM supply

See B2B Material

02MAT

Technology adopters

MAT cultivation and precision smart farms

See MAT

03ROADMAP

Investors & institutions

Growth roadmap, IP and production infrastructure

See the roadmap

04PIPELINE

Research & pharma

API standardization and the pipeline

See the pipeline

01 / 08

MARKET CONTEXT

01 / STANDARDIZATION · OPPORTUNITY

Botanicals shut out by the wall of standardizationA $54.7B botanical drug market awaits the answer

STANDARDIZATION

WSB plant compound standardization

MAT precision control regulates light, temperature, water and minerals to standardize compounds inside the pharma-spec band.

API CONTENT

PHARMA SPEC

CONVENTIONAL

WSB

CONVENTIONAL

±35%

WSB

<10%

WSB batch data · full-panel HPLC

OPPORTUNITY

Botanical drug market $54.7B

The FDA-aligned global botanical drug market grows from $54.7B in 2026 to $79.7B by 2031. Entry has one prerequisite, a standardized API supply.

GLOBAL MARKET 2026

$54.7B

MARKET 2031E

$79.7B

CAGR +7.8%

MARKET 2031E

CAGR 2026 ~ 2031

+7.8%

02 / 08

CORE TECHNOLOGY

02 / MAT

MATWe trigger the plant's own defenseto surface active compounds

Precise control of light, temperature, water, and minerals guides plants to produce more active compounds, more consistently.

Precision stressors applied in stages induce secondary metabolite production and maximize active compound yield.

So every batch ships the same active-compound content, reliably.

MAT · METABOLITE AGRICULTURE TECHNOLOGY

STRESS CHAMBERUV-B 285NM

PRECISION-OBSERVED

FAC-MAT-CHMBR

STRESSOR 01

UV-B Light

285nm

Targeted wavelength induces metabolite synthesis

STRESSOR 02

Thermal Shock

±ΔT

Heat and cold pulses trigger defense pathways

STRESSOR 03

Water Deficit

−40% H₂O

Controlled drought stress

STRESSOR 04

Mineral Cue

EC 1.4

Specific nutrient blends activate biosynthesis routes

GINSENG · PANAX

API YIELD

Control

1×

WSB smart farm

+8×

Basis · in-house trial vs. same-cultivar control

03 / 08

REGULATORY FIT

The FDA's five guidelinesWSB is built around the core requirements

GUIDELINE FIT

0/5ADDRESSED

03 / FDA STANDARDIZATION

The FDA's five core requirements for botanical drug approval. Conventional cultivation cannot meet them all at once. WSB's precision-controlled smart farm and MAT address all five.

NO

FDA GUIDELINE

WSB SOLUTION

01

Botanical identity of raw material

Only genetically validated seeds. DNA marker verification of identity

02

Good Agricultural and Collection Practices

Digital SOP controls every environmental variable. Every step logged as data

03

Contaminant control

Closed-type fully isolated facility. Heavy metals, pesticides, and microbes blocked at source

04

Consistency of quality

Active compound consistency across batches. Chemical fingerprint database built

05

Long-term stability

365-day identical-condition production. Long-term supply stability data secured

WSB SOLUTION

Only genetically validated seeds. DNA marker verification of identity

04 / 08

PROVEN CAPABILITY

04 / CAPACITY & EVIDENCE

Backed by dataSupported by production scale

MAT and the precision smart farm prove active-compound gains and batch consistency with data, backed by the Yeoncheon production center's capacity and our clinical material supply record.

SAPONIN ↑
BATCH VARIATION
CLINICAL API
ANNUAL CAPACITY: 2.52M
SITE AREA: 11,158㎡
FLOOR AREA: 5,774㎡

Precision vertical farm production hall

Precise observation · botanical material R&D

Yeoncheon R&D production center

PARTNER NETWORK

We work with partners in Korea and abroad across solution, material, and brand. Publishable contracts and milestones appear in News as they progress.

See partnership updates in News

05 / 08

BUSINESS MODEL

05 / 3 PILLARS

Technology · Material · BrandA three-pillar vertical stack

PRECISION FARM3-IN-1

PRECISION CONTROL

FAC-SOL-01

PILLAR 01

B2B Solution

Technology as a product

MAT recipes, control software, and smart farm facilities in one integrated supply that closes the technology gap at once.

DELIVERY MODEL

3-IN-1

Recipe, control software, and facility as one

Digital cultivation recipe (SOP) transfer
Precision control software supply
Smart farm facility build-out

Technology inquiry

cGMP PROCESSAPI

QC · STANDARDIZED

FAC-MAT-02

PILLAR 02

B2B Material

Standardized API supply

A stable revenue base, producing cGMP-ready API-oriented materials and nutraceutical and cosmetic botanicals in-house.

CLINICAL API SUPPLIED

100kg

Crohn's-disease botanical API

API-oriented clinical material supply
Nutraceutical and cosmetic botanical ODM

Material / ODM inquiry

HYDRO GINSENG3 SKU

BIO-VERIFIED

FAC-BRD-03

PILLAR 03

Phytopresso

Validating value as a brand

A hydroponic-ginseng premium healthcare brand that validates our technology in the market.

PRODUCT LINE

3 SKU

Hydroponic Ginseng SHOT · Angelica DECURSIN · Dendropanax CGA

B2C distribution outsourced to an influencer-marketing specialist
Run as a separate storefront

Brand partnership

06 / 08

GROWTH ROADMAP

06 / 3 PHASES

Woori Smart Bio growth roadmap

From the home marketto the global botanical drug standard

On an FDA-ready foundation and proven record, WSB expands from global raw-material supplier to botanical data platform.

PHASE 01

by 2027

Foundation and validation

GACP certification and FDA botanical-drug guideline alignment
Lead the B2B high-potency botanical material market
Commercialize three or more pipelines beyond ginseng

PHASE 02

by 2030

Global expansion and scale-up

Full-scale export of MAT-AI smart farm solutions
Registered FDA botanical drug API supplier
Operate cGMP-grade API mass production

PHASE 03

2031 onward

Market leadership and standards

Core API supplier in the global botanical drug market
Botanical data platform on proprietary cultivation and bioactive data
AI-driven new-material discovery and personalized healthcare

07 / 08

LATEST UPDATES

07 / NEWS

Latest updates

Contracts, clinical supply, and certifications in progress.

See all news

07 / NEWS · 0

No news posted yet.

08 / 08

PARTNERSHIP INQUIRY

08 / CONTACT

Let's start aglobal partnership

API supply, technology solutions, clinical collaboration. We reply within two business days.

HEADQUARTERS

149 Chaok-ro Yeoncheon-eup Yeoncheon-gun Gyeonggi-do

TEL

+82-31-834-4515

EMAIL

dasom@woorismartbio.com

RESPONSE TIME

Within two business days

View on Google Maps